CLL Support Association

Dr Susan O'brien and Dr Kanti Rai

Dr Susan O’Brien

When a doctor with a world-wide reputation in CLL gives a report, and then the report is commented upon by Dr Kanti Rai, then it is time to seriously listen or read.

This is information from real experts.

While the ‘ news ‘ is not truly new, it is laid out in simple terms that idelalisib will give a 97% response rate.

That is a truly amazing figure and fantastic news.

Read more at :-

Hopefully it will not be too long before these drugs are available. Certainly having the FDA put them on a ‘fast-track’ program is good news.


1 Reply

Thanks for sharing this. It is great that so many new agents are in the pipeline.


You may also like...